Company Analysis

Xtant Medical Holdings, Inc. (XTNT)

NYSE: XTNT · Surgical & Medical Instruments & Apparatus · Belgrade, MT · filing with the SEC since 2009
Grade5.2
◀ Past 2.9● Present 6.6▶ Future 5.7
1 est.

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Report filedMar 31, 2026Mar 6, 2025Apr 1, 2024Mar 7, 2023Mar 8, 2022Feb 24, 2021Mar 5, 2020Apr 1, 2019Apr 2, 2018Mar 29, 2017
Revenue133,927,000117,267,00091,303,00057,969,00055,263,00053,337,00064,682,00072,203,00082,612,00090,002,736
Cost of revenue49,654,00049,051,00035,836,00025,832,00022,773,00018,945,00022,166,00028,717,00032,511,000r27,710,014
Gross profit84,273,00068,216,00055,467,00032,137,00032,490,00034,392,00042,516,00043,486,00050,101,000r62,292,722
Research and development2,102,0002,385,0001,336,000915,000870,000657,000932,0001,702,0002,441,000r3,410,600
Sales and marketing45,512,00049,214,00038,439,00022,515,00021,025,00020,983,00026,493,000r31,464,000r40,511,000r44,055,813
General and administrative29,375,00028,691,00025,850,00015,462,00014,449,00013,503,00017,344,000r14,277,000r15,246,000r15,762,531
Total operating expenses76,989,00080,290,00065,625,00038,892,00036,344,00035,143,00044,769,000103,564,00087,935,000r69,837,986
Operating income7,284,000-12,074,000-10,158,000-6,755,000-3,854,000-751,000-2,253,000-60,078,000-37,834,000r-7,545,264
Interest expense3,671,0004,160,0002,938,0001,692,000995,0005,976,0005,772,00010,145,00014,705,000r12,262,750
Interest and investment income94,000·149,00031,000······
Other income (expense), net73,000-33,000-49,000···-98,000r3,000-75,000r-351,914
Total non-operating income (expense)-283,000-4,188,0009,121,000-1,661,000-995,000-5,976,000-5,870,000-10,021,000-14,577,000r-11,897,926
Income before income taxes7,001,000-16,262,000-1,037,000-8,416,000-4,849,000-6,727,000-8,123,000-70,099,000-52,411,000r-19,443,190
Income tax expense2,028,000187,000-1,697,00069,000·296,00098,000r·050,362
Net income4,973,000-16,449,000660,000-8,485,000-4,849,000-7,023,000-8,221,000-70,099,000-52,411,000r-19,493,552
Earnings per share, basic0.04-0.120.01-0.09-0.06-0.25-0.63-5.97-34.76-18.46r
Earnings per share, diluted0.03-0.120.01-0.09-0.06-0.25-0.63-5.97-34.76-18.46r
Weighted average shares, basic139,531,791133,665,075119,093,68794,085,19785,456,17528,499,84713,163,93111,740,5501,507,7691,055,937r
Weighted average shares, diluted150,042,556133,665,075126,793,31894,085,19785,456,17528,499,84713,163,93111,740,5501,507,7691,055,937r
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-12 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:Revenues
us-gaap:SalesRevenueNet
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfGoodsAndServicesSold
Gross profit revenue less the cost of what it soldus-gaap:GrossProfit
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
Sales and marketing the cost of finding and serving customersus-gaap:SellingAndMarketingExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpense
us-gaap:InterestExpenseNonoperating
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
SI Assistanton XTNT · research, not advice